C4X Discovery
C4X Discovery is a UK-based biotech company, founded in 2008 as a spin-out from the University of Manchester.
The company's differentiated approach to drug discovery is driven by enhanced DNA-based target identification and candidate molecule design capabilities, generating small molecule drug candidates across multiple disease areas including inflammation, oncology, neurodegeneration and addictive disorders.
Latest C4X Discovery News & Features
3 January 2024
1 August 2023
10 January 2023
28 November 2022
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze